Gordian Group, LLC – Trademark Portfolio
Entity Type: 16
Gordian Group, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include GORDIAN, LET THE BAD TIMES ROLL, and LAISSEZ LES MAUVAIS TEMPS ROULEZ. The owner is based in New York, NY.
950 Third Avenue 17th Floor
New York, NY 10022
Showing of trademarks Trademarks
Trademark Classifications
Gordian Group, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Gordian Group, LLC have?
Gordian Group, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Gordian Group, LLC file in?
Gordian Group, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Gordian Group, LLC's most well-known trademarks?
Gordian Group, LLC's registered trademark portfolio includes well-known marks such as GORDIAN, LET THE BAD TIMES ROLL, and LAISSEZ LES MAUVAIS TEMPS ROULEZ. These are among 3 currently registered trademarks in the portfolio.
What is Gordian Group, LLC's trademark registration success rate?
Gordian Group, LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.